Method for detecting diester alkaloids in traditional Chinese medicinal materials through UPLC-CAD-DAD method
Through the UPLC-CAD-DAD method, the C18 reverse phase chromatography column and gradient elution technology were used, combined with electro-atom type and diode array detector, the problem of difficult separation of diester alkaloids in traditional Chinese medicinal materials was solved, and the new The efficient qualitative and quantitative detection of aconitine, hypoconitine and aconitine are suitable for the quality control of traditional Chinese medicinal materials.
Patent Information
- Application Number
- CN202411148028.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-21
- Publication Date
- 2024-11-29
AI Technical Summary
The structure of diester-type alkaloids in traditional Chinese medicinal materials is similar to that of physical and chemical properties, which makes it difficult to separate. The existing detection methods are progressing slowly, making it difficult to achieve efficient qualitative and quantitative detection of neoacon, subacon and aconitine.
UPLC-CAD-DAD method, using C18 reverse phase chromatography column, octadecylsilane bonded phase filler, acetonitrile and ammonium acetate gradient elution, combined with electro-atomic atom and diode array detectors, to achieve dual-dual Qualitative and quantitative detection of ester alkaloids.
It realizes qualitative and quantitative detection of neoacon, subacontinent and acontinent, with high resolution, simple detection methods and strong specificity, suitable for quality control of traditional Chinese medicinal materials, ensuring the accuracy of alkaloid content .
Smart Images

Figure CN119044348A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of detection technology, and in particular to a method for detecting diester alkaloids in traditional Chinese medicines using a UPLC-CAD-DAD method. Background Art
[0002] Diester alkaloids are a special class of alkaloids, whose molecular structure has two ester bonds at C-14 and C-8. This type of alkaloids is found in high concentrations in Aconitum, mainly including aconitine, mesaconitine and mesaconitine. These diester alkaloids have a spicy taste and are extremely toxic, and are the main toxic components of Aconitum.
[0003] The establishment of chromatographic detection and analysis methods will help accelerate the further analysis and research of effective components of Chinese herbal medicines, and also provide technical support for the quality control of alkaloid-related products in Chinese herbal medicines in the future. However, due to the similarity of the structure and physical and chemical properties of alkaloids in Chinese herbal medicines, the separation is difficult and the research progress is slow.
[0004] In view of this, this application is filed. Summary of the invention
[0005] The invention provides a method for detecting diester alkaloids in traditional Chinese medicines by using a UPLC-CAD-DAD method, which can simultaneously perform qualitative and quantitative detection on neoaconitine, hypoaconitine and aconitine in a sample.
[0006] The present invention solves the technical problem by adopting the following technical solutions: A method for detecting diester alkaloids in traditional Chinese medicine by UPLC-CAD-DAD, wherein the detection conditions are as follows: using a C18 reverse phase chromatographic column, using an octadecylsilane bonded phase as a filler, a flow rate of 0.2-0.4 mL / min, an injection volume of 1-5 μL, a column temperature of 25-40° C., using acetonitrile as a mobile phase A, and using an aqueous solution of ammonium acetate as a mobile phase B for gradient elution; The diester alkaloid is at least one of metaaconitine, hypaconitine and aconitine.
[0007] As a preferred embodiment of the present invention, the diester type alkaloids are neoaconitine, hypoaconitine and aconitine.
[0008] As a preferred embodiment of the present invention, the specification of the chromatographic column is 100×2.1 mm.
[0009] As a preferred embodiment of the present invention, the detection conditions during the detection are: the pH of the aqueous solution of ammonium acetate is 8-11.
[0010] As a preferred embodiment of the present invention, the gradient elution conditions are specifically as follows: 0-5 min, the volume fraction of mobile phase A is 30%, and the volume fraction of mobile phase B is 70%; 5-15 min, the volume fraction of mobile phase A changes to 30-40%, and the volume fraction of mobile phase B changes to 70-60%; 15-30 min, the volume fraction of mobile phase A changes to 40-90%, and the volume fraction of mobile phase B changes to 60-10%; 30-35 min, the volume fraction of mobile phase A is 30%, and the volume fraction of mobile phase B is 40%.
[0011] As a preferred embodiment of the present invention, the CAD (short for charged aerosol detector) detection conditions are: data acquisition frequency 10 Hz, filter 1.0, atomizer temperature 35-55°C.
[0012] As a preferred embodiment of the present invention, the DAD (short for diode array detector) detection condition is: 190~400nm.
[0013] As a preferred embodiment of the present invention, the method is specifically: The reference solution is analyzed by an ultra-high performance liquid chromatograph prepared with CAD and DAD to obtain a standard chromatogram; The test solution is subjected to ultra-high performance liquid chromatography (ULCP) equipped with CAD and DAD to obtain the spectrum of the test solution, and the spectrum of the test solution is compared with the standard color spectrum to conduct qualitative analysis of the components; The content of ingredients was calculated by external standard method.
[0014] As a preferred embodiment of the present invention, the preparation method of the reference solution is: taking the aconitum diester type alkaloid reference extract and diluting it with acetonitrile to a concentration of 5-20 μg / ml.
[0015] As a preferred embodiment of the present invention, the method for preparing the test solution is: taking the Chinese medicinal material to be tested and diluting it with acetonitrile to a concentration of 5-20 μg / ml.
[0016] As a preferred embodiment of the present invention, the Chinese medicinal material contains Aconitum, Aconitum kusnezoffii or Aconitum root.
[0017] The beneficial effects of the present invention are as follows: (1) The detection method of the present invention can simultaneously perform qualitative and quantitative detection on neoaconitine, mesaconitine and aconitine in a sample; (2) Under the chromatographic conditions of the present invention, diester-type alkaloids can be well separated, and the separation degree is maintained above 2, thereby ensuring the accuracy of the alkaloid content. The detection method is more convenient, simple, highly specific and stable, and can be used for quality control of relevant Chinese medicinal materials. BRIEF DESCRIPTION OF THE DRAWINGS
[0018] Figure 1This is an ultra-high performance liquid chromatography-diode array detector spectrum.
[0019] Figure 2 This is an ultra-high performance liquid chromatography-charged aerosol detector spectrum. DETAILED DESCRIPTION
[0020] In order to make the purpose, technical solution and advantages of the embodiments of the present invention clearer, the technical solution in the embodiments of the present invention will be described clearly and completely below. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0021] The reagents or instruments used in the present invention without indicating the manufacturer are all conventional products that can be obtained through commercial purchase. Unless otherwise specified, the components and raw materials used in the embodiments and comparative examples of the present invention are all commercially available raw materials, and the components and raw materials used in each parallel experiment are all of the same kind.
[0022] Example 1 1. Instruments, reagents and methods 1. Instrument: Vanquish Horizon ultra-high performance liquid chromatograph equipped with a CAD model VH-D20-A and a DAD model VF-D11-A.
[0023] 2. Method: The reference solution was analyzed by ultra-high performance liquid chromatography equipped with CAD and DAD to obtain a standard chromatogram; The test solution is subjected to ultra-high performance liquid chromatography (ULCP) equipped with CAD and DAD to obtain the spectrum of the test solution, and the spectrum of the test solution is compared with the standard color spectrum to conduct qualitative analysis of the components; The content of ingredients was calculated by external standard method.
[0024] 3. Preparation of reference solution: dilute the aconitum diester-type alkaloid reference extract with acetonitrile to a concentration of 10 μg / ml.
[0025] 4. Preparation of test solution: Grind Aconitum kusnezoffii into powder, and then dilute it with acetonitrile to a concentration of 5-20 μg / ml.
[0026] 5. Test conditions: Chromatographic conditions: C18 reverse phase column with octadecylsilane bonded phase as filler, flow rate 0.3 mL / min, injection volume 2 μL, column temperature 30 °C, acetonitrile as mobile phase A, ammonium acetate aqueous solution (pH 10) as mobile phase B for gradient elution; The gradient elution conditions are specifically as follows: from 0 to 5 min, the volume fraction of mobile phase A is 30%, and the volume fraction of mobile phase B is 70%; from 5 to 15 min, the volume fraction of mobile phase A changes to 30 to 40%, and the volume fraction of mobile phase B changes to 70 to 60%; from 15 to 30 min, the volume fraction of mobile phase A changes to 40 to 90%, and the volume fraction of mobile phase B changes to 60 to 10%; from 30 to 35 min, the volume fraction of mobile phase A is 30%, and the volume fraction of mobile phase B is 40%.
[0027] The CAD detection conditions are: data acquisition frequency 10HZ, filter 1.0, and atomizer temperature 45℃.
[0028] DAD detection conditions: 235 nm.
[0029] In order to prove the effectiveness of this method, the methodological validation was carried out according to the above method, the retention time and peak area were recorded respectively, and the relative standard deviation was calculated. The experimental results showed that the three alkaloids achieved a baseline separation greater than 1.5; Precision: The samples were injected in parallel 6 times, the relative standard deviation of retention time was 0.04%, and the RSD of the peak areas of metaconitine, aconitine and mesaconitine using the CAD detector were 0.37%, 0.26% and 0.51% respectively; the RSD of the peak areas of metaconitine, aconitine and mesaconitine using the DAD detector were 0.81%, 0.57% and 0.42% respectively.
[0030] Detection limit: CAD detector (neoaconitine 0.0624ppm, aconitine 0.1260ppm, hypoaconitine 0.0331ppm) DAD detection limit (neoaconitine 2.7027ppm, aconitine 1.4150ppm, hypoaconitine 0.5825ppm).
[0031] Standard curve: Accurately measure 1 ml of the above-mentioned control extract solution, place it in 2 ml, 5 ml, 10 ml, and 25 ml volumetric bottles, dilute to the mark with acetonitrile solution, and shake well. Accurately measure the control extract solution and the above-mentioned series of concentration control extract solutions and inject them into the liquid chromatograph for determination. Draw the standard curve with the concentration of the control extract equivalent to mesaconitine, mesaconitine, and aconitine as the horizontal axis and the peak area value of the corresponding chromatographic peak as the vertical axis.
[0032] CAD detector standard curve: Neoaconitine y = 0.4786x-0.9599 R 2 = 0.9985.
[0033] Aconitine: y = 0.5122x-0.6745 R 2 = 0.9991.
[0034] Hypoaconitine: y = 1.1262x-1.8475 R 2 = 0.9994.
[0035] DAD detector standard curve: Neoaconitine: y = 3.7116x-20.022 R 2 = 0.9992.
[0036] Aconitine: y = 3.959x-22.93 R 2 = 0.9989.
[0037] Hypoaconitine: y = 10.215x-66.678 R 2 = 0.9991.
[0038] With the above-mentioned ideal embodiments of the present invention as inspiration, through the above-mentioned description, relevant personnel can make various changes and modifications without departing from the technical concept of the present invention. The technical scope of the present invention is not limited to the contents of the specification, and its technical scope must be determined according to the scope of the claims.
Claims
1. A method for detecting diester alkaloids in traditional Chinese medicine by UPLC-CAD-DAD, characterized in that: The detection conditions during the detection were: using a C18 reverse phase column, using octadecylsilane bonded phase as filler, flow rate 0.2~0.4mL / min, injection volume 1~5μL, column temperature 25~40℃, acetonitrile as mobile phase A, and ammonium acetate aqueous ammonia solution as mobile phase B for gradient elution; The diester alkaloid is at least one of metaaconitine, hypaconitine and aconitine.
2. The method for detecting diester alkaloids in Chinese medicinal materials by UPLC-CAD-DAD according to claim 1, characterized in that: The specification of the chromatographic column is 100×2.1 mm.
3. The method for detecting diester alkaloids in Chinese medicinal materials by UPLC-CAD-DAD according to claim 1, characterized in that: The detection conditions during the detection are: the pH of the aqueous solution of ammonium acetate is 8-11.
4. The method for detecting diester alkaloids in Chinese medicinal materials by UPLC-CAD-DAD according to claim 1, characterized in that: The gradient elution conditions are specifically as follows: from 0 to 5 min, the volume fraction of mobile phase A is 30%, and the volume fraction of mobile phase B is 70%; from 5 to 15 min, the volume fraction of mobile phase A changes to 30 to 40%, and the volume fraction of mobile phase B changes to 70 to 60%; from 15 to 30 min, the volume fraction of mobile phase A changes to 40 to 90%, and the volume fraction of mobile phase B changes to 60 to 10%; from 30 to 35 min, the volume fraction of mobile phase A is 30%, and the volume fraction of mobile phase B is 40%.
5. The method for detecting diester alkaloids in Chinese medicinal materials by UPLC-CAD-DAD according to claim 1, characterized in that: The CAD detection conditions are: data acquisition frequency 10HZ, filter 1.0, atomizer temperature 35~55℃.
6. The method for detecting diester alkaloids in Chinese medicinal materials by UPLC-CAD-DAD according to claim 1, characterized in that: DAD detection conditions are: 190~400nm.
7. The method for detecting diester alkaloids in Chinese medicinal materials by UPLC-CAD-DAD according to claim 1, characterized in that: The method is specifically as follows: The reference solution is analyzed by an ultra-high performance liquid chromatograph prepared with CAD and DAD to obtain a standard chromatogram; The test solution is subjected to ultra-high performance liquid chromatography (ULCP) equipped with CAD and DAD to obtain the spectrum of the test solution, and the spectrum of the test solution is compared with the standard color spectrum to conduct qualitative analysis of the components; The content of ingredients was calculated by external standard method.
8. The method for detecting diester alkaloids in Chinese medicinal materials by UPLC-CAD-DAD according to claim 1, characterized in that: The preparation method of the reference solution is as follows: taking the aconitum diester type alkaloid reference extract and diluting it with acetonitrile to a concentration of 5-20 μg / ml.
9. The method for detecting diester alkaloids in Chinese medicinal materials by UPLC-CAD-DAD according to claim 1, characterized in that: The preparation method of the test solution is: take the Chinese medicinal material to be tested and dilute it with acetonitrile to a concentration of 5-20 μg / ml.
10. The method for detecting diester alkaloids in Chinese medicinal materials by UPLC-CAD-DAD according to claim 1, characterized in that: The Chinese medicinal materials contain Aconitum, Aconitum kusnezoffii or Aconitum root.
Citation Information
Patent Citations
Limit detection method for aconitum diester alkaloid of tendon injury and bone setting tincture
CN117740994A
